| Economics of dental services H Sintonen, I Linnosmaa Handbook of health economics 1, 1251-1296, 2000 | 130 | 2000 |
| Omaishoidon tuki-Selvitys omaishoidon tuen palkkioista ja palveluista kunnissa vuonna 2012 I Linnosmaa, S Jokinen, A Vilkko, A Noro, E Siljander THL, 2014 | 56 | 2014 |
| Costs of multimorbidity: a systematic review and meta-analyses PB Tran, J Kazibwe, GF Nikolaidis, I Linnosmaa, M Rijken, J van Olmen BMC medicine 20 (1), 234, 2022 | 51 | 2022 |
| Provider altruism in health economics MM Galizzi, T Tammi, G Godager, I Linnosmaa, D Wiesen THL, 2015 | 47 | 2015 |
| European prices of newly launched reimbursable pharmaceuticals–a pilot study J Martikainen, I Kivi, I Linnosmaa Health Policy 74 (3), 235-246, 2005 | 46 | 2005 |
| Comparing internet and face-to-face surveys as methods for eliciting preferences for social care-related quality of life: evidence from England using the ASCOT service user measure EC Saloniki, J Malley, P Burge, H Lu, L Batchelder, I Linnosmaa, ... Quality of Life Research 28, 2207-2220, 2019 | 37 | 2019 |
| SOTE-uudistuksen vaikutusten ennakkoarviointi M Erhola, M Vaarama, M Pekurinen, PM Jonsson, M Junnila, ... THL, 2014 | 35 | 2014 |
| Cost‐effectiveness of routine and group programs for treatment of obese children M Kalavainen, S Karjalainen, J Martikainen, M Korppi, I Linnosmaa, ... Pediatrics International 51 (5), 606-611, 2009 | 29 | 2009 |
| Physician altruism and moral hazard:(no) Evidence from Finnish national prescriptions data G Crea, MM Galizzi, I Linnosmaa, M Miraldo Journal of health economics 65, 153-169, 2019 | 27 | 2019 |
| Price-cost margin in the pharmaceutical industry: empirical evidence from Finland I Linnosmaa, R Hermans, T Hallinen The European Journal of Health Economics, formerly: HEPAC 5, 122-128, 2004 | 24 | 2004 |
| Carer social care-related quality of life outcomes: estimating English preference weights for the Adult Social Care Outcomes Toolkit for Carers L Batchelder, J Malley, P Burge, H Lu, EC Saloniki, I Linnosmaa, ... Value in health 22 (12), 1427-1440, 2019 | 23 | 2019 |
| Impact of generic substitution on pharmaceutical prices and expenditures in OECD countries C Buzzelli, A Kangasharju, I Linnosmaa, H Valtonen Journal of Pharmaceutical Finance Economics and Policy 15 (1), 41, 2006 | 23 | 2006 |
| Parallel importation of pharmaceuticals in Finland: effects on markets and expenditures I Linnosmaa, T Karhunen, I Vohlonen Pharmaceutical Development and Regulation 1, 67-74, 2003 | 20 | 2003 |
| Cost-minimization analysis of treatment of gastroesophageal reflux disease: Implications of varying holding time on conclusions A Kivioja, I Linnosmaa, A Vehviläinen, I Vohlonen European journal of pharmaceutical sciences 21 (2-3), 171-178, 2004 | 19 | 2004 |
| The association between freedom of choice and effectiveness of home care services M Steffansson, M Pulliainen, A Kettunen, I Linnosmaa, M Halonen International Journal of Integrated Care 16 (1), 2016 | 17 | 2016 |
| Palvelusetelit sosiaalipalveluissa I Linnosmaa THL, 2012 | 16 | 2012 |
| Public health care providers and market competition: the case of Finnish occupational health services E Kankaanpää, I Linnosmaa, H Valtonen The European Journal of Health Economics 12, 3-16, 2011 | 16 | 2011 |
| Sosiaali-ja terveyspalvelujen vaikuttavuuden ja kustannusvaikuttavuuden tutkiminen J Miettinen, K Selander, I Linnosmaa Uudistuva sosiaali-ja terveysala, 2020 | 14 | 2020 |
| Reference pricing in Finnish pharmaceutical markets: Pre-policy evaluation M Galizzi, S Gishlandi, J Hokkanen, A Kangasharju, I Linnosmaa, ... Sosiaali-ja terveysministeriö, 2009 | 13 | 2009 |
| Translation, cultural adaptation and construct validity of the German version of the Adult Social Care Outcomes Toolkit for informal Carers (German ASCOT-Carer) B Trukeschitz, A Hajji, J Litschauer, J Malley, A Schoch, S Rand, ... Quality of Life Research 30 (3), 905-920, 2021 | 11 | 2021 |
